Navigation Links
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Date:4/16/2008

sectional diameter of 4 mm. Patients easily insert and remove NUVARING by using their fingers to press the sides of the ring together and gently push it into the vagina. The exact positioning of NUVARING within the vagina is not critical for the product to work because NUVARING is not a barrier contraceptive and therefore cannot be incorrectly inserted. Upon insertion, NUVARING begins to release a steady flow of hormones and works to prevent pregnancy on a monthly basis.

To prevent pregnancy for a full month, the vaginal ring must be inserted according to the instructions set forth in the product labeling and left in place for three consecutive weeks. This means that the ring is removed three weeks later on the same day of the week as it was inserted and at about the same time. NUVARING can be removed by hooking the index finger under the forward rim or by grasping the rim between the index and middle finger and pulling it out. After a one-week break, during which a withdrawal bleed usually occurs, a new ring is inserted on the same day of the week as it was removed.

Important Safety Information

NUVARING(R) does not protect against HIV infection and other sexually transmitted diseases. The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, which may lead to stroke or heart attack. NUVARING(R) is not for women with a history of these conditions or for women with certain cancers or those who may be pregnant. The risk of getting blood clots may be greater with the type of progestin in NUVARING(R) than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NUVARING(R) use than with the use of certain birth control pills. Cigarette smoking increases the risk of serious cardiovascular side effects, especially in women over 35; women who use combination hormonal contraceptives are strongly advised not to
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2009)...RSIPPANY, N.J., Jan. 6 Pacira Phar...ceutical company, announced today that enrollment,...E trials to evaluate the,safety and efficacy of a...M),(DepoBupivacaine) for prolonged postoperative ...morrhoidectomy and in total knee,arthroplasty (TK...
(Date:1/5/2009)...THESDA, Md., Jan. 5 Micr... company developing novel, proprietary,antibodies...oimmune diseases,provides an outlook on key even...met intends to provide an update on its research a..., -- April 12 to 16, 2009: Update on severa...
(Date:12/30/2008)...GTON, Dec. 30 The Coali...e citizen petition filed by Genentech, Inc. on Dec...laboratories to offer diagnostic tests to physicia... in laboratory tests, would harm patient care and ... , The Coalition,s mission is to encourage the re...
(Date:12/27/2008)...N DIMAS, Calif., Dec. 27 According...e best advised to consume modest doses of,resvera...ically provided in 3,to 5 glasses of aged, red wi...: http://www.newscom.com/cgi-bin/prnh/20080603/L...a-dose resveratrol alone fails to prolong,the lif...
Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Molecular Breast Imaging Identifies Occult Cancer 31228 1Molecular Breast Imaging Identifies Occult Cancer 31228 2Sigma Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT 28R 29 Single Wall Carbon Nanotubes 9489 1Sigma Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT 28R 29 Single Wall Carbon Nanotubes 9489 2Sigma Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT 28R 29 Single Wall Carbon Nanotubes 9489 3Drink Brewed Tea to Avoid Tooth Erosion 31224 1Drink Brewed Tea to Avoid Tooth Erosion 31224 2Drink Brewed Tea to Avoid Tooth Erosion 31224 3Prostate Cancer Stimulates Nerve Growth 31221 1Prostate Cancer Stimulates Nerve Growth 31221 2
...ARLSBAD, CA, May 31, 2007 /PRNewswire-FirstCall/,-...als, Inc. today,announced that preliminary data fr...sented at the American Society of Clinical,Oncolog...e data,from a Phase II clinical study of OGX-011 i... a Phase I/II clinical study of,OGX-011 in non-sma...
...t the Pediatric Academic Societies, Annual Meeting...imo SET Pulse,Oximetry Technology Can Reduce the R...y 30, 2007 /PRNewswire/ -- Masimo, the,inventor of...,Perfusion pulse oximetry, reported that a new ind... Societies, (PAS) Annual Meeting,in Toronto, Canad...
Other Medicine Technology:OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 2Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 4
(Date:1/8/2009)...Jan. 8 A proposal by th...nd Sailors Children,s Home has prompted the 125,00...revamp its annual Mid-Winter conference January 10... members, nearly unanimous opposition to the propo...re than $50,000 in direct and in-kind support to t...
(Date:1/8/2009)...versity and Baxter Healthcare Corporation will cre...liance, the two entities announced today. , Unde...fund research-collaboration projects at Northweste...mately $1 million, and Baxter will determine speci.... Aligned with Baxter,s diversified business model...
(Date:1/8/2009)... Jan. 8 The physicians of Northern...clinics in three northern Illinois,communities, a...ealth Care . , (Photo: http://www.newscom....ive internal medicine physicians serve patients th...urnee, Lindenhurst and Fox Lake. , "The Nor...
(Date:1/8/2009)... available in French . -->, ,Researcher...the McGill University Health Centre (RI MUHC) and ...entre, along with colleagues at other Canadian and...ons in a gene that increases susceptibility to dev... in the January issue of the journal Nature Genet...
Breaking Medicine News(10 mins):Health News:Baxter and Northwestern University partner to target new life sciences projects 2Health News:Northern Lake Medical to Join Aurora Health Care 2Health News:Northern Lake Medical to Join Aurora Health Care 3Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 3
...alth minister Manto Tshabalala-Msimang who has und... was announced// by the minister’s medical team. ... Unit at the Johannesburg Hospital and Wits Univer...d this liver transplant very urgently and that she...
... and over with early stage breast cancer who do no...ed risk of a local recurrence// or development of ...gnosed with breast cancer are sixty-five and over....men are less likely to be offered chemotherapy, ho...
...acute respiratory syndrome (SARS) epidemic in Chin... the spread of other respiratory diseases// , acco...sue of Clinical Infectious Diseases, currently ava...ers of SARS transmission in Guangzhou province and...
...ists have developed a modifying agent which could ... more effective, and easier to produce//. The dev...refront of any bird flu pandemic struggling to acc... and drugs produced and stockpiled by developed co...
Other Medicine News:Health News:Study Identifies Risk Factors for Spread of Respiratory Infections in Hospitals 2Health News:Brazilian Boost for Bird Flu Vaccines 2Health News:Brazilian Boost for Bird Flu Vaccines 3
Stat Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 32 tests.
For use with catalog #0540.
Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies.
Antigenic Free Protein S, ELISA Method
Medicine Products: